XORTX Therapeutics Inc. (TSXV:XRTX)
Canada · Delayed Price · Currency is CAD 2.950
0.00 (0.00%)
At close: Jul 14, 2026
XORTX Therapeutics Market Cap
XORTX Therapeutics has a market cap or net worth of CAD 5.11 million as of July 14, 2026. Its market cap has increased by 6.26% in one year.
Market Cap
5.11M
Enterprise Value
4.78M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
2.95
Market Cap Chart
Since January 11, 2018, XORTX Therapeutics's market cap has decreased from 31.46M to 5.11M, a decrease of -83.77%. That is a compound annual growth rate of -19.24%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 14, 2026 | 5.11M | -4.77% |
| Dec 30, 2025 | 5.36M | -8.88% |
| Dec 30, 2024 | 5.88M | 1.50% |
| Dec 29, 2023 | 5.80M | -64.03% |
| Dec 30, 2022 | 16.12M | -50.37% |
| Dec 31, 2021 | 32.47M | 175.88% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2018 | Upgrade Pro | Upgrade Pro |
| Jan 11, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Marvel Biosciences | 10.08M |
| Glow Lifetech | 8.66M |
| MYND Life Sciences | 5.22M |
| Restart Life Sciences | 5.19M |
| Kane Biotech | 5.13M |
| PharmaTher Holdings | 4.55M |
| Innovotech | 4.36M |
| Quest PharmaTech | 4.23M |